Table 1 SE-lncRNAs in cance
SE-lncRNAs | Cancer | interact with oncogenes or pathway | Ref |
|---|---|---|---|
LINC01977 LINC00880 LINC01503 | LUAD LUAD NSCLC | TGF-β/SMAD3 pathway PI3K/AKT pathway LASP1 | 17 18 19 |
LINC01503 CCAT1 LINC00094 LINC00094 | HNSCC ESCC ESCC CSCC | ERK signaling and AKT signaling TP63/SOX2-CCAT1-EGFR cascade TCF3, KLF5 MMP-1, MMP-13, collagen I | 20 21 22 23 |
lncRNA HCCL5 LncRNA-DAW LINC01004 LINC01089 HSAL3 | HCC HCC HCC HCC HCC | ZEB1 Wnt/b-catenin pathway E2F1 ERK/Elk1/Snail axis NOTCH signaling | 24 12 25 26 27 |
CCAT1-L AC005592.2 LINC00857 | CRC CRC CRC | MYC OLFM4 SLC1A5/ASCT2 | 28 29 30 |
TM4SF1-AS1 | STAD | T cell-mediated immune killing function | 34 |
RP11-379F4.4 RP11-465B22.8 DSCAM-AS1 | DCIS DCIS BRCA | RARRES1 miR-200b FOXA1 and ERα apoERα, p300, GATA3, FoxM1 and CTCF | 35 35 36 37 |
ATP1A1 − AS1 | BRCA | ATP1A1 | 38 |
MANCR CHPT1-eRNA | CRPC CRPC | migration and invasion CHPT1 | 39 40 |
LINC00162 | BLCA | PTTG1IP | 41 |
LIMD1-AS1 TMEM44-AS1 LINC00945 | Glioma Glioma Glioma | interferon signaling Myc and EGR1/IL-6 signaling proliferation, EMT, migration, and invasion | 42 43 44 |
TP53TG1 LOC100506178 SUCLG2-AS1 | NPC NPC NPC | malignant phenotypes MICAL2 SOX2 | 45 46 47 |